Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

The objective of this study was to evaluate the pharmacokinetics of indinavir in human immunodeficiency virus-infected children as part of a prospective, open, uncontrolled, multicenter study in The Netherlands. Human immunodeficiency virus type 1-infected children were monitored over 6 months of tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Burger, David M., van Rossum, Annemarie M. C., Hugen, Patricia W. H., Suur, Marja H., Hartwig, Nico G., Geelen, Sibyl P. M., Scherpbier, Henriette J., Hoetelmans, Richard M. W., Vulto, Arnold G., de Groot, Ronald
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2001
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC90359/
https://ncbi.nlm.nih.gov/pubmed/11181346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.3.701-705.2001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars